Hasnain Jan1
Muzamil Shah1Hazrat Usman1
Muhammad Aslam Khan1,2
Muhammad Zia1
Christophe Hano3,4*
Bilal Haider Abbasi1,3,4*- 1Department of Biotechnology, Quaid-i-Azam University, Islamabad, Pakistan
- 2Department of Biotechnology, International Islamic University, Islamabad, Pakistan
- 3Laboratoire de Biologie des Ligneux et des Grandes Cultures, INRAE USC1328, Université d’Orléans, CEDEX2, Orléans, France
- 4COSMACTIFS, Bioactifs et Cosmétiques, CNRS GDR3711, Orléans, France
Herein, we report a facile, economic, one-pot green synthesis of zinc oxide nanoparticles (ZnO-NPs) for diverse biomedical applications. In the study, ZnO-NPs were synthesized using an aqueous extract of Aquilegia pubiflora as an effective reducing and capping agent. The biomediated nanoparticles were characterized using various techniques including high-performance liquid chromatography (HPLC), X-ray diffraction, Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy, Dynamic light scattering, photoluminescence, and RAMAN. The particles were highly pure, having an average size of 34.23 nm with spherical or elliptical morphology, and displayed good aqueous dispersion capability. FTIR and HPLC confirmed the successful capping of flavonoids and hydroxycinnamic acid derivatives. The characterized NPs were then explored for their antimicrobial and anti-leishmanial potential. Among the tested bacterial and fungal strains, ZnO-NPs were more potent toward Pseudomonas aeruginosa and Fusarium solani with inhibition zone of 10.3 ± 0.19 mm and 13 ± 1.4 mm, respectively. A dose-dependent cytotoxic effect was observed against Leishmania tropica (KWH23) with significant IC50 for both the promastigote (48 μg/mL) and amastigote form (51 μg/mL) of the parasite. In addition, bacterial kinase enzymes were inhibited by ZnO-NPs, thus allowing us to elaborate a possible action mechanism. Finally, the remarkable biocompatible nature of the particles was confirmed against freshly isolated human red blood cells (hRBCs). Altogether, these results affirmed the high antimicrobial and antiparasitic potential of ZnO-NPs obtained through a biogenic synthetic approach using aqueous extract of the Himalayan Columbine (Aquilegia pubiflora).
Graphical Abstract. Schematic flow for synthesis and Biomedical application of ZnO-NPs.
Introduction
In recent years, the development of environmentally friendly techniques for the synthesis of nanoscale materials has become a major focus for material scientists (Iravani, 2011). In this regard, plant-based synthesis of NPs is a growing trend in green chemistry that is considered facile, inexpensive, and nontoxic (Bala et al., 2015; Duan et al., 2015). Over the past decade, extensive research on metal oxide NPs has been focused due to their numerous applications in various technological sectors (Altavilla and Ciliberto, 2011). Among metallic nanoparticles, zinc oxide nanoparticles (ZnO-NPs) are promising inorganic materials with multifaceted advantages. Excellent optical, semiconducting, and piezoelectric properties and chemical sensing make ZnO-NPs to be exploited across various industries such as composites, cosmetics, catalysis, energy storage, electronics, textile, and health (Hatamie et al., 2015; Kumar and Rao, 2015; Kumar et al., 2015; Al-Naamani et al., 2016; Sankapal et al., 2016). The NPs are nontoxic, biocompatible, and inexpensive and exhibit various biomedical applications including their use as antimicrobial and antiparasitic agents (Cai et al., 2016).
Currently, ZnO-NPs are commonly synthesized through physical and chemical means. The chemical approaches include sol-gel, hydrothermal, spray pyrolysis, sonochemical, solvothermal, and electrodeposition while the commonly used physical techniques include thermal evaporation, pulsed-laser deposition, molecular beam epitaxy, and chemical laser deposition (Ameen et al., 2015; Fan et al., 2015; Mani and Rayappan, 2015; Sonker et al., 2015; Suntako, 2015; Wang et al., 2015).
Though chemical and physical methods for synthesis of ZnO-NPs offer a couple of advantages, they suffer from considerable drawbacks. The physical methods of synthesis are accompanied with high-energy requirements while chemical synthesis involves the use of noxious chemicals, making both the methods environment unfriendly, expensive, and laborious (Diallo et al., 2015).
To overcome the problems of hazardous waste and energy, green synthesis of NPs has been proposed and successfully harnessed for the synthesis of ZnO-NPs; therefore, a paradigm shift can be observed toward the bio-nano interface. Among the various biological resources (plants, bacteria, algae, and fungi), plants provide an ideal platform for the biosynthesis of NPs (Thema et al., 2015). The biogenic synthesis of ZnO-NPs has already been demonstrated; however, limited data is available on their diverse biological properties.
Here, we report a rapid, room-temperature synthesis of the ZnO-NPs via a complete environmentally friendly procedure which involves the use of aqueous extracts of Aquilegia pubiflora as an effective oxidizing/reducing as well as capping agent. A. pubiflora is an important native plant with well-documented medicinal uses. Traditionally, the plant is used for varied ailments including hepatitis, wound healing, treatment of skin burns, jaundice, and circulatory and cardiovascular diseases (Hussain et al., 2011; Adnan et al., 2012; Ahmed and Murtaza, 2015; Thatoi et al., 2016). Owing to its ease of availability and medicinal importance, the plant was employed for biosynthesis of ZnO-NPs for a broad range of therapeutic applications.
To the best of our knowledge, it is the first-ever report on A. pubiflora-mediated synthesis of ZnO-NPs. The NPs were well characterized by high-performance liquid chromatography (HPLC), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), scanning electron microscopy (SEM), Raman spectroscopy, and photoluminescence (PL). The well-characterized NPs were then investigated for their antimicrobial and anti-leishmanial and protein kinase (PK) inhibition potential. Moreover, to ensure the biocompatible nature hemocompatibility of the NPs against freshly isolated human red blood cells (hRBCs) was also investigated.
Materials and Methods
Collection and Processing of the Plant Material
The herb reported in the current study was collected from District Swat (Main Damm), Khyber Pakhtunkhwa, Pakistan. The plant was taxonomically identified as A. pubiflora at the Department of botany, Bacha Khan University, Charsadda, and later on verified at the Department of Plant Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
The fresh and fine leaves of the plant were excised into small pieces through a sterile surgical blade, rinsed well with distilled water to remove any dust particles and impurities, followed by shade drying. The well-dried leaves were then ground into fine powder in a Willy mill and stored at 25°C for aqueous extraction.
Aqueous leaf extract of plant material was prepared by adding 30 g of fine powder in flasks (500 ml) containing 200 ml of distilled water, sonicated continuously for 10 min, and kept in a shaking incubator at 200 rpm for 2 days at 37°C. The prepared extract was initially filtered twice with nylon cloth to remove solid residues, and the obtained extract was further filtered using Whatman filter paper three times to remove any remaining particulates. The fresh filtrate was then processed for further use.
HPLC Analysis
Samples were analyzed by HPLC following aqueous extraction as described above. The HPLC system was composed of a Varian HPLC system with a Varian Prostar 230 pump, a Metachem Degasit degasser, a Varian Prostar 410 autosampler, and a Varian Prostar 335 Photodiode Array Detector (PAD). The HPLC system was driven by Galaxie version 1.9.3.2 software (Varian, Le Plessis-Robinson, France). HPLC-grade standards were obtained from Sigma-Aldrich. The technique used for separation is adapted from Bourgeois et al. (2016). Here, Hypersil PEP 300 C18, 250 × 4.6 mm, 5 μm particle size equipped with a guard column Alltech, 10 × 4.1 mm, was used at 35°C. Compound detection was achieved at 280 nm. The mobile phase was composed of a mixture of solvent A = HCOOH/H2O, pH = 2.1, and solvent B = CH3OH (HPLC-grade solvents). The mobile-phase composition varied during a 1-h run, with a nonlinear gradient as follows: 8% B (0 min), 12% B (11 min), 30% B (17 min), 33% B (28 min), 100% B (30–35 min), and 8% B (36 min) at a flow rate of 1 mL/min. A 10-min re-equilibration was applied between each run. Quantification was based on external 5-point calibration curves with R2 of at least 0.999 using commercial reference standards (Sigma-Aldrich; Table 1). All the samples were analyzed thrice, and the results expressed in μg/mg DW of the sample.
Table 1. Quantification parameters of the HPLC method used.
Biosynthesis of ZnO Nanoparticles
Zinc oxide nanoparticles were synthesized according to a previously described protocol with slight modifications (Thema et al., 2015). Briefly, 6.0 grams of zinc acetate dihydrate (Zn (CH3COO)2⋅2H2O (Sigma-Aldrich) was added to 100 ml extract and kept on a magnetic stirrer at 60°C for 2 h. Once the reaction was completed, the mixture was allowed to cool down at 25°C, centrifuged (HERMLE Z326K) at 10,000 rpm for 10 min. The supernatant was discarded and the remaining pellet was washed thrice with distilled water, poured into a clean Petri plate, and oven-dried at 90°C. The dried material was then grounded into fine powder in pestle and mortar and calcinated for 2 h at 500°C to remove any impurities. The annealed powder was stored in an airtight glass vial, labeled as ZnO-NPs, and was further used for physical characterization and biological applications.
Physicochemical and Morphological Characterization
Several characterization techniques including XRD, FTIR, PL, SEM, RAMAN spectroscopy, dynamic light scattering (DLS), and dispersion studies were carried out to evaluate the structural, chemical, vibrational, and morphological properties of biosynthesized ZnO-NPs. To determine the crystalline nature, XRD (Model-D8 Advance, Germany) was carried out in the range of 2 O (10°–80°) with a step time of 0.55 s and scanning step size of 0.03 °/s. Diffraction data were obtained through Cu Kα radiation (wavelength, 1.5406 Å; generator voltage, 40 kV; and tube current, 30 mA). About 1 mg of powdered ZnO-NPs was used for analysis. To calculate the crystallite size, Scherer’s equation was used as follows:
where D denotes crystallite size, k represents the shape factor (0.94), λ depicts the X-ray wavelength which was 1.5421 Å, and β and θ refer to the full width at half maximum in radians and Bragg’s angle, respectively. To determine the associated functional groups on NPs, with capping and reducing agents within the extract as a result, FTIR and HPLC were carried out. The dispersion stability of the particles was investigated visually in distilled water with varied pH as a function of storage time. Morphological attributes were examined through SEM. DLS of biogenic ZnO-NPs was performed to determine the zeta potential and size distribution. RAMAN spectroscopy of biogenic ZnO-NPs was performed in the spectral range of 200 to 700 cm–1 to find the vibrational modes of NPs while room temperature PL spectra were determined in the spectral range of 500 to 900 nm.
Antibacterial Assay
The agar well diffusion method, as documented, previously was used with some modifications for the assessment of in vitro bactericidal potential of ZnO-NPs against different bacterial strains (Thatoi et al., 2016). The seeding density (1 × 106 CFU/mL) of the bacterial culture was optimized. 50 μL of refreshed cultures in nutrient broth was used to prepare lawn on the nutrient agar plates. Each well was carefully filled with 10 μL of the test sample. Accordingly, the seeded plates were labeled. Cefixime and roxithromycin (standard antibiotics), and DMSO acted as positive and negative controls, respectively. After incubation for 24 h at 37°C, each well loaded with tested samples and positive–negative controls were checked for the appearance of a zone of inhibition (ZOI). The diameter of zones was measured in mm with a Vernier caliper.
Antifungal Assay
The agar well diffusion method (Ahmad et al., 2016) with slight modifications, was used to evaluate the antifungal potency of ZnO-NPs. In brief, a sterile SDA medium was poured in autoclaved plates and a 100-μL spore suspension of every fungal strain was taken and swabbed on solidified media in Petri plates. Each tested sample (10 μL) was applied into sterilized wells in the agar plates. The seeded plates were labeled accordingly. DMSO and clotrimazole were carried as negative and positive control, respectively. Plates were incubated at 28°C for 24–48 h to visualize the fungal growth. After incubation, each loaded disk with tested samples, and controls was checked for the appearance of ZOI (zone of inhibition). The diameter of ZOI was measured using a Vernier caliper to the nearest mm.
Protein Kinase Assay
Protein kinase enzyme inhibition assay was performed to verify the PK inhibition ability of anti-cancerous potentials of biogenic ZnO-NPs with slight modifications in protocol elucidated by Fatima et al. (2015). A medium (TSB broth) was made ready, autoclaved at 121°C for 20 min, and incubated for 24 h to confirm any impurity. Both Streptomyces strains and autoclaved TSB broth were kept in a shaking incubator at 30°C for 24 h. Except for agar, starch, and calcium carbonate, all the remaining ingredients were added with 300 mL of distilled water and mixed constantly with a stirrer. Starch, calcium carbonate, and agar were dissolved in 200 mL of distilled water in a separate flask. Both the solutions were finally mixed to make the final concentration of 500 mL. The medium was autoclaved and emptied to autoclaved Petri plates under antiseptic conditions to avoid contamination. The medium was kept solidified, and Streptomyces strain in the culture broth was uniformly spread on the surface of the media with autoclaved cotton buds. A sterile borer was used for making wells, and molten agarose was added to the bottom of the wells to avoid diffusion of the test samples. Afterward, 20 μL of the serially diluted sample was added to each well and kept intact for a few minutes to avoid aggregation of the poured sample in wells. Surfactin was assessed as positive control. Petri plates were properly labeled and kept for incubation at 37°C for 24–48 h. Using a Vernier caliper, zones of inhibition were measured in mm after 48 h, respectively.
Anti-leishmanial Assay
The anti-leishmanial potential of the biogenic ZnO-NPs was assessed against the amastigote and promastigote cultures of L. tropica KWH23 (Department of Biotechnology, BKUC, Pakistan; Ahmad et al., 2015). M199 media having 10% fetal bovine serum helped in the culture of leishmanial parasites. Leishmania culture at a density of 1 × 106 cells/mL was used for the analysis. The activity was executed in a 96-well plate with concentrations ranging from 400 to 25 μg/mL. DMSO was used as blank, and amphotericin was used as a positive control. The seeded 96-well plate with test dilutions was incubated at room temperature for 72 h. OD was noted at 540 nm, while all the lived cultures were counted using an inverted microscope, and their LC50 values were calculated by applying TableCurve software. Percent inhibition was measured as
Biocompatibility of ZnO Nanoparticles With RBCs
The biocompatibility of ZnO-NPs was probed against freshly isolated hRBCs to assess the bio-safe nature (Matinise et al., 2017). About 1 mL of blood was collected from healthy individuals with informed consent. The isolated blood was poured in the EDTA tube to prevent blood clotting. For isolation of erythrocytes, blood was centrifuged at 12,000 rpm for 7 min. Once centrifugation was completed, the supernatant was discarded, and the remaining pellet was washed three times with phosphate-buffered saline (PBS). 200 μL of erythrocyte suspension was mixed with 9.8 mL of PBS (pH: 7.2) and gently shook for preparing PBS–erythrocyte suspension. Different concentrations of NPs along with prepared erythrocyte suspension were taken in eppendorf tubes and incubated for 1 h at 35°C. All the reaction mixtures were centrifuged at 10,000 rpm for 10 min after incubation. 200 μL of the supernatant was transferred from each tested sample in a 96-well plate, and absorption was recorded for hemoglobin release at 540 nm (0.5%). Triton X-100 was used as a positive control while DMSO was employed as a negative control. Percentage hemolysis was calculated as
Results and Discussion
Synthesis and HPLC Analysis of Green ZnO-NPs
In the current study, an aqueous leaf extract ofA. pubiflora was utilized as a reducing and stabilizing agent for the synthesis of multifunctional ZnO-NPs. To the best of our knowledge, it is the first-ever study on A. publiflora-mediated synthesis of metallic nanoparticles. Genus Aquilegia belongs to the family Ranunculaceae that has more than 60 plant species, which are used for several medicinal purposes around the world, mainly in South Asia. The species are rich in medicinally important phytochemicals including aquilegiolide, apigenin, β-sitosterol, berberine, caffeic acid, genkwanin, glochidionolactone A, ferulic acid, magnoflorine, p-coumaric acid, and resorcylic acid (Bylka et al., 2002; Yu et al., 2007; Mushtaq et al., 2016). These phytochemicals including phenolics and flavonoids could have played an essential role in the synthesis of stable nanoparticles. To determine and quantify the specific phytochemicals responsible for reducing and successful capping, HPLC was performed. A total of eight compounds including four flavonoids (vitexin, isovitexin, orientin, and isoorientin) and four hydroxycinnamic acid derivatives (sinapic acid, chlorogenic acid, ferulic acid, and p-coumaric acid) were detected and quantified for both aqueous leaf extract and synthesized ZnO-NPs, as shown in Figure 1. Flavonoids and hydroxycinnamic acids are phenolics, produced through the shikimic acid pathway and are responsible for performing various biological activities of plants (Nazir et al., 2019; Santos-Sánchez et al., 2019; Usman et al., 2020). HPLC results (Table 1) indicate the presence of higher concentrations of both flavonoids and hydroxycinnamic acid derivatives for leaf extract as compared to ZnO-NPs (Table 2). Among the detected flavonoids, orientin was observed to be present in higher concentrations for both leaf extract and ZnO-NPs (707.56 μg/g DW and 45.59 μg/g DW, respectively) while chlorogenic acid was found to be abundant hydroxycinnamic acid for both leaf extract (1.70 μg/g DW) and ZnO-NPs (0.129 μg/g DW) as compared to other hydroxycinnamic acid derivatives. Orientin and chlorogenic acid protect the plant from stress conditions and perform various biological activities such as antioxidant, antiaging, anti-inflammatory, antidiabetic, antifungal, antibacterial, hepatoprotective, and anticancer (Lam et al., 2016; Naveed et al., 2018). The presence of flavonoids and hydroxycinnamic acid derivatives on the surface of nanoparticles is according to the results of our previous reports (Jan et al., 2020; Shah et al., 2020). These plant active compounds are considered to be involved in the capping of ZnO-NPs, as shown in Figure 2. After subsequent steps of washing, drying, grinding, and calcination, white powder of ZnO-NPs was obtained. The fine powder collected was stored in an airtight glass vial, labeled as ZnO-NPs, and was stored at room temperature for physicochemical, morphological characterization, and biological applications.
Figure 1. Bioactive compounds with successful capping on ZnO-NPs as identified by HPLC.
Table 2. HPLC analysis of the A. publiflora leaf extract and biosynthesized ZnO-NPs.
Figure 2. Mechanistic approach for the synthesis of ZnO-NPs through plant active compounds.
Physicochemical and Morphological Characterization
XRD (X-Ray Diffraction) Analysis
The phase identification, structure, and purity of the biosynthesized ZnO-NPs were investigated through XRD. The XRD pattern (Figure 3A) confirmed the pure and crystalline nature of nanoparticles with strong diffraction peaks observed at different 2, i.e., 31.74, 34.34, 36.36, 47.39, 56.31, 62.68, 66.83, 68.23, and 69.47°, corresponding to different miller indices (100), (002), (101), (102), (110), (103), (200), (212), and (201), respectively. The indexation confirms the standard hexagonal wurtzite structure (JCPDF file no. 00-036-1451) of ZnO-NPs as previously reported in other studies (Arakha et al., 2015; Janaki et al., 2015; Vijayakumar et al., 2016; Matinise et al., 2017). Moreover, the average crystallite size as calculated by Scherer’s equation was found to be 19.58 nm.
Figure 3. (A) Typical XRD pattern of ZnO-NPs. (B) Typical FTIR spectra of ZnO-NPs.
Fourier Transform Infrared Spectroscopy
Fourier transform infrared spectroscopy was used to examine the surface adsorption of functional groups on biosynthesized nanoparticles. Figure 3B depicts typical FTIR spectra in the spectral range of 400–4000 cm–1. The major absorption peaks were observed in the region of lower wave numbers. A broad band observed at 3100 cm–1 corresponds to the O–H stretching mode of hydroxyl groups (Vijayalakshmi et al., 2016). The peak intensity at 1459 cm–1 showed amine (–NH) vibration stretch in protein amide linkages (Jamdagni et al., 2018). The intense bands observed at 1028 cm–1 and 1384 cm–1 represented alcohols, phenolic groups, and C–N stretching vibrations of aromatic amines of biomolecules (Huang et al., 2007). A characteristic band observed at 863 cm–1 corresponds to the Zn–O stretching bond (Taş et al., 2000; Sangeetha et al., 2011). FTIR spectra affirm successful capping of biomolecules on the NP surface and thus provide stability and dispersion capacity to ZnO-NPs in aqueous media.
Scanning Electron Microscopy Analysis
The surface morphology and particle size of the green synthesized ZnO-NP were determined using SEM. Figures 4A,B show typical scanning electron micrograph NPs. As can be seen from the micrographs, the particles exhibit a sphere-shape morphology with extent of aggregation. Such morphologies were also reported in previous studies (Davar et al., 2015; Suresh et al., 2015; Khan et al., 2018). For instance, in a study, sphere-shaped nanoparticles were reported using aqueous leaf extract of three plants, i.e., Abutilon indicum, Clerodendrum infortunatum, and Clerodendrum inerme. Moreover, the average particle size of the nanoparticles as calculated using ImageJ software was found to be 34.23 nm.
Figure 4. Typical SEM micrograph of ZnO-NPs (A) at 1 μm and (B) at 200 nm. (C) Pictorial presentation of dispersion studies of ZnO-NPs at varied pH as a function of storage time.
Dispersion Studies
Dispersion plays a vital role in determining functional activities of the engineered nanoparticles in any biological system (Bihari et al., 2008). Several parameters affect the dispersion capacity of the nanoparticles such as presence of charged or uncharged molecules that are adsorbed on the particle surface and the ionic strength of the solvent (Modena et al., 2019). In order to investigate the dispersion capability of ZnO nanoparticles, distilled water at different pH values was used. Figure 4C illustrates the dispersion capacity of ZnO-NPs at pH: 2, pH: 7, and pH: 12. It was observed that ZnO exhibited excellent dispersibility at neutral pH even after 24 h of sonication. The results were later augmented by a highly negative zeta potential value at neutral pH, which quantifies the stable dispersion capability of nanoparticles.
Dynamic Light Scattering
Zeta potential and size distribution of the particles was investigated using a Malvern zeta sizer. Zeta potential (ζ) is a typical measurement of the surface charge and defines colloidal stability of the particles. Suspensions that feature | ζ| ≥ 15 mV are generally categorized as stable colloids (Modena et al., 2019). The zeta potential of synthesized ZnO-NPs in distilled water was recorded as −18.4 mV and can thus be considered as stable colloidal solution in Figures 5A,B. The measurement augments and verifies the stable dispersion capability of biogenic ZnO nanoparticles in distilled water with pH 7. The negative surface charge on particles is due to the high binding affinity of the extract compounds on metallic ions conferring the particles’ dispersion stability and preventing from aggregation (Vimala et al., 2014). Moreover, size distribution measurements revealed the average size of the particles to be 131 nm with a polydispersity index (PDI) of 0.340. As the graph shows, the particle size is polydispersed and is larger as compared to the SEM measurements. The larger size of the ZnO-NPs observed via DLS is due to the biasness of the technique toward measurement of larger particles (even aggregate; Modena et al., 2019).
Figure 5. (A) Size distribution of ZnO-NPs and (B) zeta potential of ZnO-NPs, (C) Typical Raman spectra of ZnO-NPs and (D) and room temperature PL.
Photoluminescence and Raman Spectra
The photoluminescence study of engineered nanomaterials (ENMs) is important as it provides important information about the quality of the synthesized materials. Figure 5D illustrates room temperature PL spectra of ZnO-NPs. PL measurement was performed at excitation wavelength of 500 to 900 nm. Characteristic peaks were observed at 510, 552, and 690 nm referred to as trap-state or deep-state emission (Uthirakumar and Hong, 2009). It is proposed that the oxygen vacancies in ZnO exist in three charge states, i.e., neutral, singly ionized, and double ionized. Green emission from ZnO-NPs is due to existence of oxygen (Raoufi, 2013) related to the increase in oxygen vacancies and thus increase in PL emission. Figure 5C shows Raman spectra of the biosynthesized nanoparticles that displayed characteristic peaks at 435 and 572 cm–1. Similar Raman patterns were also reported in some previous studies (Diallo et al., 2015).
Biological Applications
Antibacterial Activity
Pathogenic bacteria and fungi cause a broad range of diseases in both humans and animals. Extensive research and sophisticated scientific approach have become inevitable for the establishment of new therapeutic values to overcome microbial resistance and the nonselective and unsystemic use of antibiotics. In the study, antibacterial activity of phyto-fabricated ZnO-NPs was determined against five pathogenic bacteria including two Gram-positive (Bacillus subtilis and Staphylococcus epidermidis) and three Gram-negative (Klebsiella pneumonia, Escherichia coli, and Pseudomonas aeruginosa) using agar well diffusion method as shown in Table 3. An example of ZnO-NP activity against S. epidermidis is shown in Figure 6A. Five different concentrations (5, 4, 2, 1, and 0.5 mg/mL) were used to probe the bactericidal potential of NP formulations. In general, all the tested strains showed dose-dependent susceptibility to ZnO-NPs with P. aeruginosa and B. subtilis found to be the most susceptible. Inhibition zones measured at 5 mg/mL were 10.3 ± 0.19 for P. aeruginosa, 9.5 ± 0.31 for Bacillus subtilis, 8.7 ± 0.18, and 8.7 ± 0.23 for both K. pneumonia and E. coli while 7.1 ± 0.24 for S. epidermidis. Most of the mechanistic models for antibacterial activity of ZnO-NPs are based on the surface-to-volume ratio, size, and physicochemical properties. Though antimicrobial mechanisms of metallic nanoparticles are subject to ongoing research, few models have been demonstrated in literature that explain the inhibitory mechanism of NPs. According to the studies, the growth inhibition effect of ZnO-NPs is the result of one or a combination of the following mechanisms: (1) electrostatic interaction between microbial cell wall and ZnO-NPs leading to cell wall destruction and thus compromise of cell integrity; (ii) accumulation of ZnO-NPs and subsequent release of Zn+2 within the bacterial cell; and (iii) formation of reactive oxygen species (ROS; Sirelkhatim et al., 2015; Król et al., 2017). Numerous studies have suggested ROS generation as a key mechanism responsible for the antimicrobial potential of ZnO-NPs. ROS results in DNA damage, disrupting cellular membranes and proteins and ultimately leading to cell death (Raghupathi et al., 2011). Hydroxyl radical (OH-), hydrogen peroxide (H2O2), and superoxide anion (O–2) are the most abundant reactive oxygen species found in aqueous suspension of ZnO-NPs. Among these, -OH is the most reactive species and reacts with any type of biomolecule within the living cells. Such biochemical reactions may lead to recombination of two -OH ions to form H2O2. Hydrogen peroxide is a relatively weak oxidizer but may also result in cell damage. Unlike -OH and H2O2, superoxide anion radical (O–2) has weak penetration potential and is less toxic (Hameed et al., 2015). These reactive oxygen species are produced on the surface of ZnO-NPs in aqueous media. In subsequent steps, the electrons and the holes on the ZnO-NP surface interact with water (H2O) molecules in the surrounding medium and form OH and H+. In separate reactions, O2 molecules yield superoxide anion (O-2), which further produces HO2⋅ by reacting with H+. Furthermore, the reaction between electrons generating (HO2) and H+ yield (H2O2) molecules, which has the capacity to penetrate cellular membranes, and ultimately damage or kill the bacteria cells (Xie et al., 2011; Sirelkhatim et al., 2015).
Table 3. Antibacterial activity of ZnO-NPs against pathogenic bacterial strains.
Figure 6. (A) Example of ZnO-NP antibacterial activity against S. epidermidis. (B) Example of ZnO-NP antifungal activity against A. niger.
Antifungal Activity
The antifungal potential of A. pubiflora-mediated nanoparticles was measured by the agar well diffusion method. The results are summarized in Table 4, though biosynthesized ZnO-NPs have been extensively studied for antibacterial operations, yet limited data is available regarding its efficacy against spore forming fungi. In the current study, ZnO-NPs were evaluated against five filamentous fungal strains with stock concentrations in the range 5000–500 μg/ml. An example of ZnO-NP activity against A. niger is shown in Figure 6B. Amphotericin B and DMSO were applied as a positive and negative control, respectively. In general, all the samples displayed dose-dependent antifungal activity. Among the tested strains, F. solani, M. racemosus, and A. niger showed a maximum ZOI at 5 mg/ml, which were measured as 13 ± 0.44, 12.7 ± 0.39, and 12.2 ± 0.44 mm, respectively, while the lowest ZOI was recorded 5.4 ± 0.24 mm for M. racemosus and 6.1 ± 0.29 mm for A. niger at 500 μg/ml. Studies suggest that membrane disruption and free radical generation are considered as the most common methods of NP-induced cellular toxicity. ROS generation and nanoparticle interaction with fungal hyphae and spores lead to fungal growth inhibition (He et al., 2011). Significant and dose-dependent fungicidal activity has also been reported in previous studies (Sharma et al., 2010; Lipovsky et al., 2011) which is in agreement with our study. Based on the significant antibacterial and antifungal activity, ZnO-NPs can be used as an effective antimicrobial material either in pristine form or in combination or carrier for antibiotics.
Table 4. Antifungal activity of CeO2-NPs against pathogenic fungi.
Protein Kinase Inhibition Activity
Protein kinase, a kinase enzyme, has a significant importance in anticancer therapies. The enzymes play a key role in the phosphorylation of serine–threonine and tyrosine residues; these residues are helpful in certain regulatory and controlling processes for metabolism, apoptosis of cells, and cellular proliferation/differentiation. Decontrolled phosphorylation can cause and induce genetic abnormalities, leading to tumorigenesis. Therefore, all those products which have the ability to deter PK enzymes can be of significant importance in cancer research (Yao et al., 2011). PK phosphorylation also plays a vital role in the formation of hyphae in Streptomyces fungal strains, and the same principal is applied to determine the PK inhibition activity. The Streptomyces 85E strain was used to investigate medicinal compounds for investigation of the PK inhibition (Waters et al., 2002). For the preliminary anticancer screening, ZnO-NPs in different concentration were evaluated for PK inhibition. DMSO and surfactin were used as negative and positive controls, respectively. Like antimicrobial activity, ZnO-NPs also displayed dose-dependent potential against PK and the highest ZOI was observed on 5 mg/mL as 17 ± 1.22 mm while the lowest ZOI was recorded as 6.3 ± 1.72 mm at 500-μg/ml concentrations, respectively, as shown in Figure 7. Such an excellent activity of ZnO-NPs is a preliminary indication of its anticancer potential and can be considered for detailed in vitro and in vivo anticancer studies.
Figure 7. (A) Assay of protein Kinase Inhibition by ZnO-NPs. (B) Quantified protein kinase inhibition (in mm) by ZnO-NPs.
Anti-leishmanial Assay
Leishmaniasis is a tropical and subtropical disease with annual incidence of 1.5 to 2 million cases worldwide. According to the World Health Organization (WHO), the disease is endemic in 89 countries and results in 70,000 deaths each year. The disease is caused by an intracellular parasite and is transmitted to humans by sand fly (phlebotomies and Lutzomyia) bite. Due to the inappropriate vector and inefficient and affordable drugs, the disease is at high risk of uncontrolled spreading. Recently, metal-oxide nanoparticle (oxides of zinc, silver, titanium, and magnesium)-based treatments have gained popularity because of their significant cytotoxic potential against Leishmania (Jebali and Kazemi, 2013). However, biosynthesized ZnO-NPs have been rarely explored for their cytotoxicity against the parasite Leishmania tropica (KWH23). In the current study, ZnO-NPs in the range of 12.5–400 μg/mL were investigated via MTT cytotoxic assay against the promastigote and amastigote axenic cultures of L. tropica (Figure 8). ZnO-NP formulations were found to have dose-dependent lethality with significant mortality of 85% ± 2.7 and 81% ± 3.1 at 400 μg/mL against the parasite in promastigote and amastigote form, its morphological form being round-shaped in human host. Least mortality observed was 26.43% ± 2.4 and 29.07% ± 2.9 at the tested concentration of 12.5 μg/mL. The IC50 values were calculated as 48 μg/mL for promastigote and 51 μg/mL for amastigote. Our findings are in agreement with previous studies and thus emphasize on the futuristic possibilities for ZnO-NPs in anti-leishmanial therapies.
Figure 8. Anti-leishmanial assay: Mortality (in %) of amastigote and promastigote parasites.
Biocompatibility Studies of ZnO-NPs
Biocompatibility of ENMs is a key requirement for their multifaceted biomedical applications. To evaluate the bio-safe nature, ZnO-NPs were investigated for their compatibility against hRBCs. In the experiment, freshly isolated hRBCs and NP formulations were co-incubated in PBS that mimic the extracellular environment (Evans et al., 2013). The assay is based on the release of hemoglobin from red blood cells (RBCs), which can be induced by the test sample if it has the capability to rupture RBCs. The RBCs lysis is then quantified by measuring the hemoglobin release in the medium spectrophotometrically (405 nm; Amin and Dannenfelser, 2006). The NPs were screened at 400 μg/mL for hemolytic activity, shown in Table 5. Generally, any hemolysis ≥ 25% is considered hemolytic while hemolysis ≤ 10% is considered nonhemolytic. In the current study, ZnO-NPs exhibited remarkable hemocompatibility even at the highest tested concentration. The study thus concludes that A. pubiflora ZnO-NPs are highly biocompatible and can be used for diverse biomedical applications.
Table 5. % Hemolytic analysis of A. pubiflora synthesized ZnO-NPs.
Conclusion
The recent research work is focused on the bioaugmented synthesis of ZnO-NPs using aqueous extract of medicinally important A. pubiflora. The crystalline nature of the synthesized NPs was confirmed by XRD analysis. HPLC and FTIR analysis confirmed the presence of phytochemicals involved during the conversion of metallic ions into nanoparticles. Morphology and vibrational modes were determined through SEM and RAMAN spectra, while surface charge and stability were determined through DLS. Synthesized ZnO-NPs showed effective antimicrobial (antibacterial and antifungal) and antiparasitic (anti-leishmanial) activities. The bioengineered ZnO-NPs have also exhibited an effective inhibitory potential against microbial PKs. It was also found that synthesized ZnO-NPs are biocompatible with hRBCs. Our experimental work concluded that the abovementioned ZnO-NPs have a great potential for various cosmetic or medicinal applications as biocompatible antimicrobial and antiparasitic agents. However, further research on ZnO-NPs to exploit its biomedical potential on both in vitro and in vivo levels has to be conducted.
Data Availability Statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation, to any qualified researcher.
Ethics Statement
Ethical review and approval was not required for the study on human participants in accordance with the local legislation and institutional requirements. The patients/participants provided their written informed consent to participate in this study.
Author Contributions
HJ performed the experiments, compiled the data, and prepared the manuscript. MS assisted in experiments. HU helped in biological assays. MK helped in characterization of NPs. MZ helped in characterization of NPs. CH performed HPLC and reviewed the manuscript. BA supervised the research and critically reviewed the manuscript. All authors contributed to the article and approved the submitted version.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
Adnan, M., Begum, S., Khan, A. L., Tareen, A. M., and Lee, I.-J. (2012). Medicinal plants and their uses in selected temperate zones of Pakistani Hindukush-Himalaya. J. Med. Plants Res. 6, 4113–4127.
Ahmad, A., Syed, F., Shah, A., Khan, Z., Tahir, K., Khan, A. U., et al. (2015). Silver and gold nanoparticles from Sargentodoxa cuneata: synthesis, characterization and antileishmanial activity. RSC Adv. 5, 73793–73806. doi: 10.1039/c5ra13206a
Ahmad, K., Talha Khalil, A., and Somayya, R. (2016). Antifungal, phytotoxic and hemagglutination activity of methanolic extracts of Ocimum basilicum. J. Tradit. Chin. Med. 36, 794–798. doi: 10.1016/s0254-6272(17)30017-1
Ahmed, M. J., and Murtaza, G. (2015). A study of medicinal plants used as ethnoveterinary: harnessing potential phytotherapy in Bheri, District Muzaffarabad (Pakistan). J. Ethnopharmacol. 159, 209–214. doi: 10.1016/j.jep.2014.11.016
Al-Naamani, L., Dobretsov, S., and Dutta, J. (2016). Chitosan-zinc oxide nanoparticle composite coating for active food packaging applications. Innovat. Food Sci. Emerg. Technol. 38, 231–237. doi: 10.1016/j.ifset.2016.10.010
Altavilla, C., and Ciliberto, E. (2011). “Inorganic nanoparticles: synthesis, applications, and perspectives,” in An Overview. Inorganic Nanoparticles: Synthesis, Applications, and Perspectives, eds C. Altavilla and E. Ciliberto (New York, NY: CRC Press), 1–17.
Ameen, S., Akhtar, M. S., and Shin, H. S. (2015). Highly dense ZnO nanowhiskers for the low level detection of p-hydroquinone. Mater. Lett. 155, 82–86. doi: 10.1016/j.matlet.2015.04.111
Amin, K., and Dannenfelser, R. M. (2006). In vitro hemolysis: guidance for the pharmaceutical scientist. J. Pharm. Sci. 95, 1173–1176. doi: 10.1002/jps.20627
Arakha, M., Saleem, M., Mallick, B. C., and Jha, S. (2015). The effects of interfacial potential on antimicrobial propensity of ZnO nanoparticle. Sci. Rep. 5:9578.
Bala, N., Saha, S., Chakraborty, M., Maiti, M., Das, S., Basu, R., et al. (2015). Green synthesis of zinc oxide nanoparticles using Hibiscus subdariffa leaf extract: effect of temperature on synthesis, anti-bacterial activity and anti-diabetic activity. RSC Adv. 5, 4993–5003. doi: 10.1039/c4ra12784f
Bihari, P., Vippola, M., Schultes, S., Praetner, M., Khandoga, A. G., Reichel, C. A., et al. (2008). Optimized dispersion of nanoparticles for biological in vitro and in vivo studies. Part. Fibre Toxicol. 5:14. doi: 10.1186/1743-8977-5-14
Bourgeois, C., Leclerc, É. A., Corbin, C., Doussot, J., Serrano, V., Vanier, J.-R., et al. (2016). Nettle (Urtica dioica L.) as a source of antioxidant and anti-aging phytochemicals for cosmetic applications. Compt. Rend. Chimie 19, 1090–1100. doi: 10.1016/j.crci.2016.03.019
Bylka, W., Frañski, R., and Stobiecki, M. (2002). Differentiation between isomeric acacetin-6-C-(6 ?-O-malonyl) glucoside and acacetin-8-C-(6 ?-O-malonyl) glucoside by using low-energy CID mass spectra. J. Mass Spectrom. 37, 648–650. doi: 10.1002/jms.313
Cai, X., Luo, Y., Zhang, W., Du, D., and Lin, Y. (2016). pH-Sensitive ZnO quantum dots-doxorubicin nanoparticles for lung cancer targeted drug delivery. ACS Appl. Mater. Interf. 8, 22442–22450. doi: 10.1021/acsami.6b04933
Davar, F., Majedi, A., and Mirzaei, A. (2015). Green synthesis of ZnO nanoparticles and its application in the degradation of some dyes. J. Am. Ceram. Soc. 98, 1739–1746. doi: 10.1111/jace.13467
Diallo, A., Ngom, B., Park, E., and Maaza, M. (2015). Green synthesis of ZnO nanoparticles by Aspalathus linearis: structural & optical properties. J. Alloys Compounds 646, 425–430. doi: 10.1016/j.jallcom.2015.05.242
Duan, H., Wang, D., and Li, Y. (2015). Green chemistry for nanoparticle synthesis. Chem. Soc. Rev. 44, 5778–5792. doi: 10.1039/c4cs00363b
Evans, B. C., Nelson, C. E., Shann, S. Y., Beavers, K. R., Kim, A. J., Li, H., et al. (2013). Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs. JoVE 2013:e50166.
Fan, F., Feng, Y., Tang, P., and Li, D. (2015). Facile synthesis and photocatalytic performance of ZnO nanoparticles self-assembled spherical aggregates. Mater. Lett. 158, 290–294. doi: 10.1016/j.matlet.2015.05.109
Fatima, H., Khan, K., Zia, M., Ur-Rehman, T., Mirza, B., and Haq, I.-U. (2015). Extraction optimization of medicinally important metabolites from Datura innoxia Mill.: an in vitro biological and phytochemical investigation. BMC Complement. Altern. Med. 15:376. doi: 10.1186/s12906-015-0891-1
Hameed, A. S. H., Karthikeyan, C., Kumar, V. S., Kumaresan, S., and Sasikumar, S. (2015). Effect of Mg2+, Ca2+, Sr2+ and Ba2+ metal ions on the antifungal activity of ZnO nanoparticles tested against Candida albicans. Mater. Sci. Eng. C 52, 171–177. doi: 10.1016/j.msec.2015.03.030
Hatamie, A., Khan, A., Golabi, M., Turner, A. P., Beni, V., Mak, W. C., et al. (2015). Zinc oxide nanostructure-modified textile and its application to biosensing, photocatalysis, and as antibacterial material. Langmuir 31, 10913–10921. doi: 10.1021/acs.langmuir.5b02341
He, L., Liu, Y., Mustapha, A., and Lin, M. (2011). Antifungal activity of zinc oxide nanoparticles against Botrytis cinerea and Penicillium expansum. Microbiol. Res. 166, 207–215. doi: 10.1016/j.micres.2010.03.003
Huang, J., Li, Q., Sun, D., Lu, Y., Su, Y., Yang, X., et al. (2007). Biosynthesis of silver and gold nanoparticles by novel sundried Cinnamomum camphora leaf. Nanotechnology 18:105104.
Hussain, I., Bano, A., and Ullah, F. (2011). Traditional drug therapies from various medicinal plants of central karakoram national park, Gilgit-Baltistan Pakistan. Pak. J. Bot. 43, 79–84.
Jamdagni, P., Khatri, P., and Rana, J. (2018). Green synthesis of zinc oxide nanoparticles using flower extract of Nyctanthes arbor-tristis and their antifungal activity. J. King Saud Univer. Sci. 30, 168–175. doi: 10.1016/j.jksus.2016.10.002
Jan, H., Khan, M. A., Usman, H., Shah, M., Ansir, R., Faisal, S., et al. (2020). The Aquilegia pubiflora (Himalayan columbine) mediated synthesis of nanoceria for diverse biomedical applications. RSC Adv. 10, 19219–19231. doi: 10.1039/d0ra01971b
Janaki, A. C., Sailatha, E., and Gunasekaran, S. (2015). Synthesis, characteristics and antimicrobial activity of ZnO nanoparticles. Spectrochimica acta Part A. Mol. Biomol. Spectrosc. 144, 17–22. doi: 10.1016/j.saa.2015.02.041
Jebali, A., and Kazemi, B. (2013). Nano-based antileishmanial agents: a toxicological study on nanoparticles for future treatment of Cutaneous leishmaniasis. Toxicol. Vitro 27, 1896–1904. doi: 10.1016/j.tiv.2013.06.002
Khan, S. A., Noreen, F., Kanwal, S., Iqbal, A., and Hussain, G. (2018). Green synthesis of ZnO and Cu-doped ZnO nanoparticles from leaf extracts of Abutilon indicum, Clerodendrum infortunatum, Clerodendrum inerme and investigation of their biological and photocatalytic activities. Mater. Sci. Eng. C 82, 46–59. doi: 10.1016/j.msec.2017.08.071
Król, A., Pomastowski, P., Rafiñska, K., Railean-Plugaru, V., and Buszewski, B. (2017). Zinc oxide nanoparticles: synthesis, antiseptic activity and toxicity mechanism. Adv. Colloid Interf. Sci. 249, 37–52. doi: 10.1016/j.cis.2017.07.033
Kumar, R., Al-Dossary, O., Kumar, G., and Umar, A. (2015). Zinc oxide nanostructures for NO 2 gas-sensor applications: a review. Nano Micro Lett. 7, 97–120. doi: 10.1007/s40820-014-0023-3
Kumar, S. G., and Rao, K. K. (2015). Zinc oxide based photocatalysis: tailoring surface-bulk structure and related interfacial charge carrier dynamics for better environmental applications. RSC Adv. 5, 3306–3351. doi: 10.1039/c4ra13299h
Lam, K. Y., Ling, A. P. K., Koh, R. Y., Wong, Y. P., and Say, Y. H. (2016). A review on medicinal properties of orientin. Adv. Pharmacol. Sci. 2016:4104595.
Lipovsky, A., Nitzan, Y., Gedanken, A., and Lubart, R. (2011). Antifungal activity of ZnO nanoparticles—the role of ROS mediated cell injury. Nanotechnology 22:105101. doi: 10.1088/0957-4484/22/10/105101
Mani, G. K., and Rayappan, J. B. B. (2015). Facile synthesis of ZnO nanostructures by spray pyrolysis technique and its application as highly selective H2S sensor. Mater. Lett. 158, 373–376. doi: 10.1016/j.matlet.2015.05.006
Matinise, N., Fuku, X., Kaviyarasu, K., Mayedwa, N., and Maaza, M. (2017). ZnO nanoparticles via Moringa oleifera green synthesis: physical properties & mechanism of formation. Appl. Surf. Sci. 406, 339–347. doi: 10.1016/j.apsusc.2017.01.219
Modena, M. M., Rühle, B., Burg, T. P., and Wuttke, S. (2019). Nanoparticle characterization: what to measure? Adv. Mater. 31:1901556. doi: 10.1002/adma.201901556
Mushtaq, S., Aga, M. A., Qazi, P. H., and Ali, M. N. (2016). Isolation, characterization and HPLC quantification of compounds from Aquilegia fragrans Benth: their in vitro antibacterial activities against bovine mastitis pathogens. J. Ethnopharmacol. 178, 9–12. doi: 10.1016/j.jep.2015.11.039
Naveed, M., Hejazi, V., Abbas, M., Kamboh, A. A., Khan, G. J., Shumzaid, M., et al. (2018). Chlorogenic acid (CGA): a pharmacological review and call for further research. Biomed. Pharmacother. 97, 67–74.
Nazir, M., Tungmunnithum, D., Bose, S., Drouet, S., Garros, L., Giglioli-Guivarc’h, N., et al. (2019). Differential production of phenylpropanoid metabolites in callus cultures of Ocimum basilicum L. with distinct in vitro antioxidant activities and in vivo protective effects against UV stress. J. Agric. Food Chem. 67, 1847–1859. doi: 10.1021/acs.jafc.8b05647
Raghupathi, K. R., Koodali, R. T., and Manna, A. C. (2011). Size-dependent bacterial growth inhibition and mechanism of antibacterial activity of zinc oxide nanoparticles. Langmuir 27, 4020–4028. doi: 10.1021/la104825u
Raoufi, D. (2013). Synthesis and microstructural properties of ZnO nanoparticles prepared by precipitation method. Renew. Energy 50, 932–937. doi: 10.1016/j.renene.2012.08.076
Sangeetha, G., Rajeshwari, S., and Venckatesh, R. (2011). Green synthesis of zinc oxide nanoparticles by aloe barbadensis miller leaf extract: structure and optical properties. Mater. Res. Bull. 46, 2560–2566. doi: 10.1016/j.materresbull.2011.07.046
Sankapal, B. R., Gajare, H. B., Karade, S. S., Salunkhe, R. R., and Dubal, D. P. (2016). Zinc oxide encapsulated carbon nanotube thin films for energy storage applications. Electrochim. Acta 192, 377–384. doi: 10.1016/j.electacta.2016.01.193
Santos-Sánchez, N. F., Salas-Coronado, R., Hernández-Carlos, B., and Villanueva-Cañongo, C. (2019). “Shikimic acid pathway in biosynthesis of phenolic compounds,” in Plant Physiological Aspects of Phenolic Compounds, eds M. S. Hernández, R. G. Mateos, and M. P. Tenango (London: IntechOpen).
Shah, M., Nawaz, S., Jan, H., Uddin, N., Ali, A., Anjum, S., et al. (2020). Synthesis of bio-mediated silver nanoparticles from Silybum marianum and their biological and clinical activities. Mater. Sci. Eng. C 112:110889. doi: 10.1016/j.msec.2020.110889
Sharma, D., Rajput, J., Kaith, B., Kaur, M., and Sharma, S. (2010). Synthesis of ZnO nanoparticles and study of their antibacterial and antifungal properties. Thin Solid Films 519, 1224–1229. doi: 10.1016/j.tsf.2010.08.073
Sirelkhatim, A., Mahmud, S., Seeni, A., Kaus, N. H. M., Ann, L. C., Bakhori, S. K. M., et al. (2015). Review on zinc oxide nanoparticles: antibacterial activity and toxicity mechanism. Nano Micro Lett. 7, 219–242. doi: 10.1007/s40820-015-0040-x
Sonker, R. K., Sabhajeet, S., Singh, S., and Yadav, B. (2015). Synthesis of ZnO nanopetals and its application as NO2 gas sensor. Mater. Lett. 152, 189–191. doi: 10.1016/j.matlet.2015.03.112
Suntako, R. (2015). Effect of zinc oxide nanoparticles synthesized by a precipitation method on mechanical and morphological properties of the CR foam. Bull. Mater. Sci. 38, 1033–1038. doi: 10.1007/s12034-015-0921-0
Suresh, D., Nethravathi, P., Rajanaika, H., Nagabhushana, H., and Sharma, S. (2015). Green synthesis of multifunctional zinc oxide (ZnO) nanoparticles using Cassia fistula plant extract and their photodegradative, antioxidant and antibacterial activities. Mater. Sci. Semiconduct. Proc. 31, 446–454. doi: 10.1016/j.mssp.2014.12.023
Taş, A. C., Majewski, P. J., and Aldinger, F. (2000). Chemical preparation of pure and strontium-and/or magnesium-doped lanthanum gallate powders. J. Am. Ceram. Soc. 83, 2954–2960. doi: 10.1111/j.1151-2916.2000.tb01666.x
Thatoi, P., Kerry, R. G., Gouda, S., Das, G., Pramanik, K., Thatoi, H., et al. (2016). Photo-mediated green synthesis of silver and zinc oxide nanoparticles using aqueous extracts of two mangrove plant species, Heritiera fomes and Sonneratia apetala and investigation of their biomedical applications. J. Photochem. Photobiol. B Biol. 163, 311–318. doi: 10.1016/j.jphotobiol.2016.07.029
Thema, F., Manikandan, E., Dhlamini, M., and Maaza, M. (2015). Green synthesis of ZnO nanoparticles via Agathosma betulina natural extract. Mater. Lett. 161, 124–127. doi: 10.1016/j.matlet.2015.08.052
Usman, H., Ullah, M. A., Jan, H., Siddiquah, A., Drouet, S., Anjum, S., et al. (2020). Interactive Effects of Wide-spectrum monochromatic lights on phytochemical production, antioxidant and biological activities of Solanum xanthocarpum callus cultures. Molecules 25:2201. doi: 10.3390/molecules25092201
Uthirakumar, P., and Hong, C.-H. (2009). Effect of annealing temperature and pH on morphology and optical property of highly dispersible ZnO nanoparticles. Mater. Charact. 60, 1305–1310. doi: 10.1016/j.matchar.2009.06.002
Vijayakumar, S., Vaseeharan, B., Malaikozhundan, B., and Shobiya, M. (2016). Laurus nobilis leaf extract mediated green synthesis of ZnO nanoparticles: characterization and biomedical applications. Biomed. Pharmacother. 84, 1213–1222. doi: 10.1016/j.biopha.2016.10.038
Vijayalakshmi, U., Chellappa, M., Anjaneyulu, U., Manivasagam, G., and Sethu, S. (2016). Influence of coating parameter and sintering atmosphere on the corrosion resistance behavior of electrophoretically deposited composite coatings. Mater. Manufact. Process. 31, 95–106. doi: 10.1080/10426914.2015.1070424
Vimala, K., Sundarraj, S., Paulpandi, M., Vengatesan, S., and Kannan, S. (2014). Green synthesized doxorubicin loaded zinc oxide nanoparticles regulates the Bax and Bcl-2 expression in breast and colon carcinoma. Process Biochem. 49, 160–172. doi: 10.1016/j.procbio.2013.10.007
Wang, M.-H., Ma, X.-Y., and Zhou, F. (2015). Synthesis and characterization of monodispersed spherical ZnO nanocrystals in an aqueous solution. Mater. Lett. 142, 64–66. doi: 10.1016/j.matlet.2014.11.126
Waters, B., Saxena, G., Wanggui, Y., Kau, D., Wrigley, S., Stokes, R., et al. (2002). Identifying protein kinase inhibitors using an assay based on inhibition of aerial hyphae formation in Streptomyces. J. Antibiot. 55, 407–416. doi: 10.7164/antibiotics.55.407
Xie, Y., He, Y., Irwin, P. L., Jin, T., and Shi, X. (2011). Antibacterial activity and mechanism of action of zinc oxide nanoparticles against Campylobacter jejuni. Appl. Environ. Microbiol. 77, 2325–2331. doi: 10.1128/aem.02149-10
Yao, G., Sebisubi, F. M., Voo, L. Y. C., Ho, C. C., Tan, G. T., and Chang, L. C. (2011). Citrinin derivatives from the soil filamentous fungus Penicillium sp. H9318. J. Brazil. Chem. Soc. 22, 1125–1129. doi: 10.1590/s0103-50532011000600018
Keywords: zinc oxide nanoparticles, green synthesis, nanomedicine, bio-compatible, phytochemicals, antibacterial and antifungal
Citation: Jan H, Shah M, Usman H, Khan MA, Zia M, Hano C and Abbasi BH (2020) Biogenic Synthesis and Characterization of Antimicrobial and Antiparasitic Zinc Oxide (ZnO) Nanoparticles Using Aqueous Extracts of the Himalayan Columbine (Aquilegia pubiflora). Front. Mater. 7:249. doi: 10.3389/fmats.2020.00249
Received: 02 December 2019; Accepted: 09 July 2020;
Published: 12 August 2020.
Edited by:
Denis Kuznetsov, National University of Science and Technology MISiS, RussiaReviewed by:
Michihiro Nakamura, Yamaguchi University, JapanDi Huang, Massachusetts Eye and Ear Infirmary and Harvard Medical School, United States
Copyright © 2020 Jan, Shah, Usman, Khan, Zia, Hano and Abbasi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Christophe Hano, christophe.hano@univ-orleans.fr; Bilal Haider Abbasi, bhabbasi@qau.edu.pk